echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Sci Rep: Scientists hope to use novel epigenetic biomarker to predict infant's risk of preterm birth

    Sci Rep: Scientists hope to use novel epigenetic biomarker to predict infant's risk of preterm birth

    • Last Update: 2022-05-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    March 6, 2022 / Bio Valley BIOON / -- Preterm birth is the leading cause of neonatal and infant death, affecting the health of nearly one in ten babies


    In this study, the researchers documented more than 100 epigenetic biomarkers in preterm mothers that differed from genetic markers in the mothers of full-term fetuses.


    Epigenetics is the molecular factors and processes surrounding DNA that determine how genes behave.


    The researchers took specimens of cheek swabs from two groups of mother-father-infant trios shortly after birth.


    Image source: https:// infants born before 37 weeks of gestation can be fatal to the infant, and many surviving infants face a variety of health problems, some of which persist for life, including intellectual disability and cardiovascular disease.


    Investigator Skinner's lab has previously published related research on potential epigenetic biomarkers, including for autism and rheumatoid arthritis, that may pave the way for the development of earlier treatments; Although researchers may not be able to solve this problem at present, as research progresses in the future, researchers may develop new tests to help potentially predict the risk of preterm birth


    Original source:

    Winchester, P.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.